Abstract
Dimethylbenzanthracene (DMBA), a strong tumor initiator, did not show mutagenic activity in the soybean test system either alone or in combination with tumor promoter, TPA. In combination treatments with DMBA and gamma-rays, the mutagenicity of gamma-rays was not affected by post-treatment with DMBA. However, DMBA pre-treatment clearly reduced gammaray-ray induced spotting frequency, suggesting that DMBA affects mutagenesis in gamma-irradiated soybean cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
